Paper40069876
Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissue.
Kasarinaite A and 13 others. Stem Cell Res Ther, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissue. Papers, record 40069876. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40069876
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissue.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver | Major topic |
| Testosterone | Major topic |
| Estrogens | Major topic |
| Fatty Liver | Major topic |
| Pluripotent Stem Cells | Major topic |
| Humans | |
| Male | |
| Female | |
| Gene Expression Regulation |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed | ||
| 219542/Z/19/Z | Wellcome Trust | United Kingdom | PubMed | |
| TS/R017581/1 | Innovate UK | PubMed | ||
| MR/R01566X/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33997816 | Protocol for automated production of human stem cell derived liver spheres. | STAR Protoc | 2021 | https://conductscience.org/library/papers/33997816 | PubMed |
| 2 | 31669262 | Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice. | Cell Mol Gastroenterol Hepatol | 2020 | https://conductscience.org/library/papers/31669262 | PubMed |
| 3 | 33409477 | A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis. | iScience | 2021 | https://conductscience.org/library/papers/33409477 | PubMed |
| 4 | 38617550 | The role of STAT3/VAV3 in glucolipid metabolism during the development of HFD-induced MAFLD. | Int J Biol Sci | 2024 | https://conductscience.org/library/papers/38617550 | PubMed |
| 5 | 35787557 | Retinol-binding protein-4 and nonalcoholic fatty liver disease. | Chin Med J (Engl) | 2022 | https://conductscience.org/library/papers/35787557 | PubMed |
| 6 | 32124935 | CYP4A11 is involved in the development of nonalcoholic fatty liver disease via ROS‑induced lipid peroxidation and inflammation. | Int J Mol Med | 2020 | https://conductscience.org/library/papers/32124935 | PubMed |
| 7 | 14713950 | Hematopoietic, angiogenic and eye defects in Meis1 mutant animals. | EMBO J | 2004 | https://conductscience.org/library/papers/14713950 | PubMed |
| 8 | 33536476 | Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease. | Sci Rep | 2021 | https://conductscience.org/library/papers/33536476 | PubMed |
| 9 | 33763069 | The Roles of Neutrophils in the Pathogenesis of Liver Diseases. | Front Immunol | 2021 | https://conductscience.org/library/papers/33763069 | PubMed |
| 10 | 35646271 | Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations. | World J Hepatol | 2022 | https://conductscience.org/library/papers/35646271 | PubMed |
| 11 | 35690649 | RNA adenosine deaminase (ADAR1) alleviates high-fat diet-induced nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome. | Lab Invest | 2022 | https://conductscience.org/library/papers/35690649 | PubMed |
| 12 | 20890895 | Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter. | Hepatology | 2010 | https://conductscience.org/library/papers/20890895 | PubMed |
| 13 | 16817817 | Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. | Clin Endocrinol (Oxf) | 2006 | https://conductscience.org/library/papers/16817817 | PubMed |
| 14 | 36793871 | Hepatic PTP4A1 ameliorates high-fat diet-induced hepatosteatosis and hyperglycemia by the activation of the CREBH/FGF21 axis. | Theranostics | 2023 | https://conductscience.org/library/papers/36793871 | PubMed |
| 15 | 36562664 | Single-cell transcriptomics of hepatic stellate cells uncover crucial pathways and key regulators involved in non-alcoholic steatohepatitis. | Endocr Connect | 2023 | https://conductscience.org/library/papers/36562664 | PubMed |
| 16 | 36626630 | The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. | Hepatology | 2023 | https://conductscience.org/library/papers/36626630 | PubMed |
| 17 | 33310085 | Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction Study. | Gastroenterology | 2021 | https://conductscience.org/library/papers/33310085 | PubMed |
| 18 | 21042596 | Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. | PLoS One | 2010 | https://conductscience.org/library/papers/21042596 | PubMed |
| 19 | 33982400 | Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). | Liver Int | 2021 | https://conductscience.org/library/papers/33982400 | PubMed |
| 20 | 37100955 | Apoptotic cell death in disease-Current understanding of the NCCD 2023. | Cell Death Differ | 2023 | https://conductscience.org/library/papers/37100955 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42806145 | A human single-cell atlas identifies OLR1+ scar-associated macrophages as a potential therapeutic target for chronic liver disease. | Nat Genet | 2026 | https://conductscience.org/library/papers/42806145 | PubMed |
| 42453276 | In vitro preclinical modeling of sex-specific biology and hormonal dynamics in women's health: insights across multiple organs. | Front Glob Womens Health | 2026 | https://conductscience.org/library/papers/42453276 | PubMed |
| 42193914 | Translating Human Prototype Liver Implant Technology from Academia to Industry for Third-Party Transplant and In Vivo Validation. | Cells | 2026 | https://conductscience.org/library/papers/42193914 | PubMed |
| 41724762 | PGC-1α protects against MASH via Tim23-dependent inhibition of DRP1-mediated ferroptosis. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41724762 | PubMed |
| 41657945 | Glycosaminoglycans in tissue regeneration: Insights into glycobiology and their biomedical application. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41657945 | PubMed |
| 41640606 | Stemness CD24 activation promotes hepatocellular carcinoma progression via an immune escape mechanism. | World J Gastroenterol | 2026 | https://conductscience.org/library/papers/41640606 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40069876
GET https://conductscience.org/api/papers/v1/40069876/references?page=2